Navigation Links
Triage Wireless Raises $20.3 Million in Series B Financing Round Led by Qualcomm Ventures
Date:3/31/2008

SAN DIEGO, March 31 /PRNewswire/ -- Triage Wireless, Inc. today announced that it closed on a $20.3 million strategic investment round led by Qualcomm Ventures. Other participants in this round included existing investors Sanderling Ventures and 3i Group and new investor, Intel Capital. To date, Triage Wireless has raised $25.8 million. The new proceeds will be used to fund the commercialization of the Company's wireless vital signs monitoring system, OmniScan(R), which features a novel proprietary method for measuring blood pressure.

"This strategic investment reflects confidence in our OmniScan Technology and its potential for mitigating the risk of medical errors and other adverse events by providing a novel approach to continuous vital signs monitoring," said Tom Watlington, Chief Executive Officer of Triage Wireless, Inc. "We are fortunate to have two premier technology companies as participants in this offering and look forward to working with them to advance wireless medical technology."

"The expanded implementation of monitoring technology in hospitals can not only improve care, but also enhance efficiency," said Nagraj Kashyap, Senior Director and head of Qualcomm Ventures. "We believe the wireless capabilities of the Triage technology will make such monitoring practical in both the hospital and the home settings, and we are pleased to participate in this offering."

About Triage Wireless, Inc.

Triage Wireless is a medical device company dedicated to development, marketing and sale of a new generation of vital signs monitoring technology that merges the benefits of wireless body-area network communication (WBAN) with improved biosensors. The first generation of new sensors allow blood pressure measurements to be made continuously for long periods of time without relying on frequent inflations of an arm-worn cuff. With its wireless capabilities, patients do not have to be tethered to the monitor and results can be sent to an
'/>"/>

SOURCE Triage Wireless, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care
2. AspenBio Outlines Steps for FDA 510(k) Clearance of AppyScore(TM), the First Blood-Based Screen/Triage Test for Human Appendicitis
3. MarketResearch.com Announces Distribution of Wireless Healthcare Research
4. On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group
5. Wireless Platforms Key to Joined-up Healthcare
6. AT4 wireless and Ekahau Partner to Deploy Combined Asset and Staff Tracking Solution for Hospitals
7. AT&T Provides In-Building Wireless Services to Thomas Jefferson University and Hospital
8. NetMotion Wireless Boosts Mobile Productivity for Visiting Nurse Service of New York
9. Colubris Partners with AeroScout to Enable Real-time Location Detection over Wireless Networks
10. Cardiac Science Corporation Selects Colubris Networks Wireless Solution for its Portable Electrocardiograph
11. Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... Reporter , , TUESDAY, May 22 (HealthDay News) -- ... procedure, which involves threading a camera through the ... But a new study has found that patients ... less time-consuming CT-based colon scan. Colonoscopy ... colon cancer screening. Computed tomography (CT) colonography -- ...
(Date:5/23/2012)... ATS 2012, SAN FRANCISCO The number of viral ... in childhood, according to a new study from researchers ... infancy predicted wheezing later in childhood, this association was ... , "Viral infections in infancy, particularly rhinovirus, are thought ... but it is unclear whether this association is due ...
(Date:5/23/2012)... tiny, resilient metal wire designed to gather and compress ... severe heterogeneous emphysema, a subtype of the disease that ... to the results of a multicenter international trial conducted ... a lung volume reduction coil (LVRC), can be easily ... more invasive procedures used to improve the lung function ...
(Date:5/23/2012)... ROCHESTER, Minn. -- Mayo Clinic researchers will present ... other urological research at the annual meeting of ... Mayo Clinic urologists will also be available to ... , Mayo Clinic studies that will be presented ... negative impact on overall survival from post-prostate surgery ...
(Date:5/22/2012)... Bend, OR Bend Research Inc., a ... announced the expansion of its existing hot-melt ... an 18mm Leistritz twin-screw mixer/extruder. , ... Research,s existing 27mm Leistritz and 19mm Baker ... and continuous high-shear wet-granulation capabilities. Many projects ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4
... for local clinics and health technology projectsPORTLAND, Ore., ... eight grants geared toward building healthier communities and ... and Washington. The grants, totaling $380,000, range from ... quality Web site."The Regence Foundation believes philanthropy is ...
... to have a synergistic effect in the development of ... is a genetic disorder, mostly resulting from mutations in ... metabolism which leads to iron accumulation that may eventually ... between iron metabolism, HFE mutations and alcoholic liver disease ...
... is manifested in a variety of tissues and cancer ... currently being studied as a novel treatment. The PPAR-gamma ... via differentiation, apoptotic induction, and changes in genes or ... have been some reports suggesting that stomach cancer cells ...
... BISMARCK, N.D., Feb. 17 Due to the ... across the United States, Bismarck and,surrounding area optometrists ... assessments for infants between six to 12 months,of ... developed,by the American Optometric Association (AOA) in partnership ...
... pressure affects use of sunscreen, coverups, study finds , , TUESDAY, ... likely to follow sun safety measures if their peers do ... in Atlanta. , Lifeguards and aquatic instructors at outdoor ... M. Hall and colleagues at the university,s Rollins School of ...
... the treatment of epilepsy in children, in many cases ... of vision. Serge Picaud, head of research at Inserm, ... have just discovered the origin of this secondary effect ... shown that vigabatrin provokes a marked decrease in the ...
Other Medicine News:Health News:Grants Strengthen the Health Care Safety Net 2Health News:Grants Strengthen the Health Care Safety Net 3Health News:What is the suppressing effect of the PPAR-gamma ligands on stomach cancer cells? 2Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 2Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 3Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 4Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 5Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 6Health News:On Sun Safety, Pool Staff May Take Cue From Others 2Health News:Taurine: Key to the visual toxicity of an anti-epileptic drug for children? 2Health News:Taurine: Key to the visual toxicity of an anti-epileptic drug for children? 3
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... and CHAPEL HILL, N.C., US, March 06, ... Orphan") and,Lantibio, Inc. ("Lantibio") today announced positive ... II clinical,study of Moli1901, an experimental compound ... developed by AOP Orphan in,Europe under a ...
... Accentia,Biopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters at,the ... Asthma, and,Immunology from February 23 - 27, 2007 ... a survey of 202 otolaryngologists,(ENTs) and allergists in ... of chronic sinusitis (CS), the knowledge and attitudes ...
Other Medicine Technology:AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5
... patented polymerase chain reaction (PCR) technology, the ... an essential component of Roches blood screening ... minute amounts of selected unique regions of ... of copies (that is, to detectable levels) ...
... market in New Technology, the Arrow International ... new first and only IABP system that ... physiologically based timing algorithm, WAVE, to deliver ... Second generation Automaticity provides for sophisticated ...
... the worlds first truly automated ... introduced a whole new level ... system modularity and ease of ... The NexES Systems automated technology ...
... is a nonprofit, physician-directed organization promoting ... patient care through programs of voluntary ... laboratory professionals in all sizes of ... laboratory accreditation, quality management services, consultation ...
Medicine Products: